Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 77
Filter
1.
Medicine ; 101(51), 2022.
Article in English | GIM | ID: covidwho-2191116

ABSTRACT

Background: This systematic review and meta-analysis aimed to assess the association of hypernatremia with the outcomes of COVID-19 patients.

2.
Enfermeria Intensiva ; 2022.
Article in English, Spanish | Scopus | ID: covidwho-2178439

ABSTRACT

Aims: To identify risk factors present in patients with dysphagia in a population of critically ill patients. Methods: Case series of a cohort of patients recruited in the intensive care unit (ICU) until hospital discharge. Patients who gave consent and met the inclusion criteria were recruited. The Volume-Viscosity clinical examination method was used for the screening of dysphagia. An uni- and bivariate statistical analysis was performed using odds ratio (OR) to detect risk factors for dysphagia. Outcomes: 103 patients were recruited from 401 possible. The mean age was 59,33±13,23, men represented 76,7%. The severity of the sample was: APACHE II (12,74±6,17) and Charlson (2,98±3,31). 45,6% of patients showed dysphagia, obtaining significant OR values (p<0,050) for the development of dysphagia: older age, neurological antecedents, COVID19, long stay in ICU and hospitalization, and the presence of tracheotomy. COVID19 patients represented 46,6% of the sample, so an analysis of this subgroup was performed, showing similar results, with a Charlson risk (OR:4,65;95% CI:1,31-16,47;p=0,014) and a hospital stay (OR: 8,50;95%CI: 2,20-32,83;p<0,001). On discharge from the ICU, 37,9% of the population still had dysphagia;12,6% maintained this problem at hospital discharge. Conclusions: Almost half of our patients developed dysphagia. Clinical severity and the presence of tracheotomy were risk factors. We observed in patients with dysphagia a longer stay in both ICU and hospitalization. © 2022 Sociedad Española de Enfermería Intensiva y Unidades Coronarias (SEEIUC)

3.
Studia Pneumologica et Phthiseologica ; 82(3):92-100, 2022.
Article in Czech | GIM | ID: covidwho-2169018

ABSTRACT

In the last two years, COVID pneumonia has frequently been dealt with by both outpatient and inpatient pulmonology centers. To describe the actual situation, we conducted a retrospective study including 200 patients admitted to the Department of Pneumology, Second Faculty of Medicine. Charles University and University Hospital in Motol during the first (autumn 2020) and fourth (autumn 2021) waves of the COVID-19 pandemic. Of those, 25% of patients died, significantly more in the first wave (33%) than in the fourth wave (17%). The mean age of the deceased was 76 years. as compared with 67 years in the entire sample. The risk factor for admissions was. besides older age, a higher number of comorbidities, with 38% of patients being obese. A negative prognostic factor was high C-reactive protein. There were fewer deaths among patients treated with remdesivir (18% vs. 30%) and those with a body mass index over 31 (17% vs. 30%). Two thirds of patients died of COVID-19;one third died with the disease. Vaccination was beneficial for patients in the fourth wave. with significantly fewer of them dying. staying in intensive care units and requiring mechanical ventilation or extracorporeal membrane oxygenation. COVID pneumonia is a severe, life-threatening disease whose course was positively influenced by vaccination. treatment and herd immunity through previous infection.

4.
Indonesian Journal of Pharmacy ; 33(3):381-393, 2022.
Article in English | CAB Abstracts | ID: covidwho-2205056

ABSTRACT

Li Coagulopathy is a common predictor of mortality in COVID-19. Meanwhile, enoxaparin is an anticoagulant with anti-inflammatory, endothelial protection, and viral antagonist properties. Therefore, thromboprophylaxis with enoxaparin in COVID-19 is common in clinical settings. This study aims to assess enoxaparin's efficacy across different severity levels by examining its effect on primary outcomes comprising Length of stay (LOS), invasive mechanical ventilation, and mortality as well as secondary in the form of D-dimer, platelets, C-reactive protein (CRP), Neutrophil Lymphocyte Ratio (NLR), and Absolute Lymphocyte Count (ALC). During hospitalization, 269 patients received enoxaparin across varying severity levels comprising mild, moderate, and severe, while the Wilcoxon test was used to analyze the efficacy in each group. Additionally, the differences in patient characteristic profiles across the severity levels were determined using the Kruskal-Wallis test. The increase in mortality rate and the need for mechanical ventilation were directly proportional to the level of severity. D-dimer decreased from 1308.87 ng/ml to 979.83 ng/ml (p=<0,001) as well as from 1758.41 ng/ml to 1510.68 ng/ml (p=<0,001) in the mild and moderate levels respectively. The platelet increased from 225.65 to 369.39 x103/ micro l (p=<0,001) in mild and 256.77 to 398.97 x103/ micro l (p=<0,001) in moderate. Moreover, CRP improved in both mild 52.62 to 49.58 mg/l (p=0.031) and moderate 92.99 to 42.66 mg/l, (p=<0,001). Based on the results, enoxaparin effectively improves D-dimer, platelet, and CRP levels in mild and moderate but not in severe conditions, however, no effect was found on LOS, NLR, and ALC.

5.
Journal of the Japanese Association for Infectious Diseases ; 96(5):173-178, 2022.
Article in Japanese | GIM | ID: covidwho-2203545

ABSTRACT

Objective: This study was aimed at clarifying the clinical characteristics and prognosis of patients hospitalized with COVID-19 and the treatment strategies for COVID-19 in each surge of the COVID-19 pandemic. Subjects and methods: We retrospectively examined the data of 358 patients with confirmed COVID-19 (116 in surge 3, 137 in surge 4, and 105 in surge 5) who were admitted to the Yoshijima Hospital.

6.
Enfermería Intensiva ; 2022.
Article in English | ScienceDirect | ID: covidwho-2165272

ABSTRACT

Resumen Objetivos Determinar los factores de riesgo presentes en los pacientes con disfagia en relación con una población de pacientes críticos. Método Serie de casos de una cohorte de pacientes reclutados en la unidad de cuidados intensivos (UCI) hasta el alta hospitalaria. Se reclutaron a aquellos pacientes que dieron su consentimiento y cumplían los criterios de inclusión. El método de exploración clínica Volumen-Viscosidad fue utilizado para la detección de la disfagia. Se realizó un análisis estadístico uni- y bivariante, a través del odds ratio (OR) para detectar los factores de riesgo en la disfagia. Resultados 103 pacientes fueron reclutados de 401 posibles. La media de edad fue de 59,33±13,23;los hombres representaban el 76,7%. La gravedad media fue: APACHE II (12,74±6,17) y Charlson (2,98±3,31). Un 45,6% de los pacientes desarrollaron disfagia, obteniendo valores significativos de OR (p<0,050) para el desarrollo de disfagia: la mayor edad, los antecedentes neurológicos, COVID19, la alta estancia en UCI y hospitalización y la presencia de traqueotomía. Los pacientes COVID19 representaban el 46,6%, por lo que se realizó un análisis de este subgrupo observando resultados similares, con un riesgo de Charlson (OR:4,65;IC95%: 1,31-16,47;p=0,014) y una estancia hospitalaria (OR: 8,50;IC95%: 2,20-32,83;p<0,001). Al alta de UCI, el 37,9% de la población presentaba todavía disfagia, y mantenía este problema al alta hospitalaria el 12,6%. Conclusiones Casi la mitad de nuestros pacientes presentaron disfagia. Fueron factores de riesgo la gravedad clínica y la presencia de traqueotomía. Se observó en estos pacientes una mayor estancia tanto en UCI como en hospitalización. Aims To identify risk factors present in patients with dysphagia in a population of critically ill patients. Methods Case series of a cohort of patients recruited in the intensive care unit (ICU) until hospital discharge. Patients who gave consent and met the inclusion criteria were recruited. The Volume-Viscosity clinical examination method was used for the screening of dysphagia. An uni- and bivariate statistical analysis was performed using odds ratio (OR) to detect risk factors for dysphagia. Outcomes 103 patients were recruited from 401 possible. The mean age was 59,33±13,23, men represented 76,7%. The severity of the sample was: APACHE II (12,74±6,17) and Charlson (2,98±3,31). 45,6% of patients showed dysphagia, obtaining significant OR values (p<0,050) for the development of dysphagia: older age, neurological antecedents, COVID19, long stay in ICU and hospitalization, and the presence of tracheotomy. COVID19 patients represented 46,6% of the sample, so an analysis of this subgroup was performed, showing similar results, with a Charlson risk (OR:4,65;95% CI:1,31-16,47;p=0,014) and a hospital stay (OR: 8,50;95%CI: 2,20-32,83;p<0,001). On discharge from the ICU, 37,9% of the population still had dysphagia;12,6% maintained this problem at hospital discharge. Conclusions Almost half of our patients developed dysphagia. Clinical severity and the presence of tracheotomy were risk factors. We observed in patients with dysphagia a longer stay in both ICU and hospitalization.

7.
Jornal Brasileiro de Pneumologia ; 48(5), 2022.
Article in English, Portuguese | CAB Abstracts | ID: covidwho-2156226

ABSTRACT

Objective: To evaluate clinical outcomes and factors associated with mortality, focusing on secondary infections, in critically ill patients with COVID-19 in three Brazilian hospitals during the first pandemic wave.

8.
Annals of Medical Research ; 29(8):858-863, 2022.
Article in English | CAB Abstracts | ID: covidwho-2113695

ABSTRACT

Aim: Pregnancy is considered a vulnerable period for women regarding increased risk of respiratory tract infections, altered immunity, and metabolic changes in their bodies. COVID-19 pandemic also possesses a significant risk on pregnant women, but the data on the disease course is insufficient. Therefore, this study aimed to evaluate the maternal and perinatal outcomes in pregnant women diagnosed with COVID-19. Materials and Methods: This cross-sectional study retrospectively evaluated the hospital records of pregnant women admitted to the Obstetrics and Gynecology Department of 19 MayisUniversity Hospital between 01/04/2020 to 30/12/2021 regarding gestational week at birth, basal gestational, and labor characteristics, delivery complications, and perinatal and maternal COVID-19 outcomes.

9.
Clinical Nephrology ; 96(4):207-215, 2021.
Article in English | GIM | ID: covidwho-2056047

ABSTRACT

Background: Continuous renal replacement therapy (CRRT) has become an important multiple organ support therapy and it is widely used in the intensive care unit (ICU). The aim of this study was to clarify the association between CRT and 28-day mortality in critically ill coronavirus disease 2019 (COVID-19) patients receiving mechanical ventilation. Materials and methods: 112 respiratory decompensated critically ill adult patients with COVID-19 admitted to a COVID-19-designated ICU were included in this retrospective cohort study. Data on demographic information, comorbidities, laboratory findings upon ICU admission, and clinical outcomes were collected. The Kaplan-Meier method and Cox proportional hazard model were applied to determine the potential risk factors associated with 28-day mortality.

10.
Am J Respir Crit Care Med ; 206(7): 846-856, 2022 10 01.
Article in English | MEDLINE | ID: covidwho-2053497

ABSTRACT

Rationale: Bacterial lung microbiota are correlated with lung inflammation and acute respiratory distress syndrome (ARDS) and altered in severe coronavirus disease (COVID-19). However, the association between lung microbiota (including fungi) and resolution of ARDS in COVID-19 remains unclear. We hypothesized that increased lung bacterial and fungal burdens are related to nonresolving ARDS and mortality in COVID-19. Objectives: To determine the relation between lung microbiota and clinical outcomes of COVID-19-related ARDS. Methods: This observational cohort study enrolled mechanically ventilated patients with COVID-19. All patients had ARDS and underwent bronchoscopy with BAL. Lung microbiota were profiled using 16S rRNA gene sequencing and quantitative PCR targeting the 16S and 18S rRNA genes. Key features of lung microbiota (bacterial and fungal burden, α-diversity, and community composition) served as predictors. Our primary outcome was successful extubation adjudicated 60 days after intubation, analyzed using a competing risk regression model with mortality as competing risk. Measurements and Main Results: BAL samples of 114 unique patients with COVID-19 were analyzed. Patients with increased lung bacterial and fungal burden were less likely to be extubated (subdistribution hazard ratio, 0.64 [95% confidence interval, 0.42-0.97]; P = 0.034 and 0.59 [95% confidence interval, 0.42-0.83]; P = 0.0027 per log10 increase in bacterial and fungal burden, respectively) and had higher mortality (bacterial burden, P = 0.012; fungal burden, P = 0.0498). Lung microbiota composition was associated with successful extubation (P = 0.0045). Proinflammatory cytokines (e.g., tumor necrosis factor-α) were associated with the microbial burdens. Conclusions: Bacterial and fungal lung microbiota are related to nonresolving ARDS in COVID-19 and represent an important contributor to heterogeneity in COVID-19-related ARDS.


Subject(s)
COVID-19 , Microbiota , Respiratory Distress Syndrome , COVID-19/complications , Critical Illness , Humans , Lung/microbiology , Microbiota/genetics , RNA, Ribosomal, 16S/genetics , Respiration, Artificial , Tumor Necrosis Factor-alpha
11.
Revista de Ciencias Sociales ; - (174):143-165,263, 2021.
Article in Spanish | ProQuest Central | ID: covidwho-2045254

ABSTRACT

En este artículo se busca identificar los determinantes en el cambio del riesgo de hospitalización con y sin intubación respecto a la atención ambulatoria de acuerdo a condiciones de indigenismo con covid-19 al inicio de la pandemia. Con información de la Secretaría de Salud de México del 22 de mayo de 2020 se elaboran modelos logísticos multinomiales para ambos grupos de pacientes, ajustando por variables socioeconómicas, condiciones de salud y lugar de residencia.Alternate :Identify the determinants of the change in the risk of hospitalization with and without and with intubation with respect to outpatient care in indigenous and non-indigenous patients according to conditions of indigenism with covid-19 at the beginning of the pandemic. With information from the Ministry of Health of Mexico on May 20, 2020, multinomial logistic models are developed for both groups of patients, adjusting for socioeconomic variables, health conditions and place of residence that show common conditions such as pneumonia and others, as well as residence in large cities for indigenous people due to their migration.

12.
Boletin de Malariologia y Salud Ambiental ; 62(2):251-259, 2022.
Article in Spanish | CAB Abstracts | ID: covidwho-2034476

ABSTRACT

Background: Invasive mechanical ventilation as a therapeutic strategy is not without complications. It is imperative to have protective ventilation parameters in those patients who are subjected to it. We aim to demonstrate whether mechanical power as a ventilatory parameter has prognostic validity for mortality in critically ill patients with prolonged invasive mechanical ventilation. Material and Methods: An analytical cross-sectional study was carried out of critically ill patients on prolonged invasive mechanical ventilation due to Acute Respiratory Distress Syndrome due to COVID-19 who were admitted to the Intensive Care Unit of the Hospital Regional de Trujillo during the March 2020 to March 2021 period.

13.
Nutrition Today ; 57(4):221-228, 2022.
Article in English | CAB Abstracts | ID: covidwho-2018348

ABSTRACT

A prominent issue for patients with SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is obesity. Some reports claim that obese patients with acute respiratory distress syndrome have better outcomes. This inverse relationship has been termed the obesity paradox and is not yet understood in patients with coronavirus disease 2019 (COVID-19) hospitalized in the intensive care unit (ICU). The aim of this study was to investigate the obesity paradox in patients with COVID-19 admitted to the ICU. In this retrospective observational study, 5230 patients with COVID-19, admitted to the ICU between June 1, 2020, and January 10, 2021, were analyzed. Body mass index (BMI) was calculated according to the World Health Organization classification, and patients were categorized as underweight, normal, overweight, or obese for statistical analysis. A Kaplan-Meier survival analysis, Cox regression model, and dose-response relationship between BMI level and ICU length of stay (LOS) and connection to the ventilator survival were conducted. Of the 5230 patients studied, 3233 (62%) had nonobese BMIs, and 2997 (38%) were obese. We found no significant difference in mortality between obese and nonobese patients with COVID-19, where 1699 patients (31%) survived. However, there were significant differences in BMI level for ICU LOS and ventilation duration (P < 0.05, P < 0.03). In multivariable Cox regression, significant differences were observed in ICU LOS and ventilation duration of patients between obese and nonobese patients (P < 0.001, P < 0.005). There was no association between BMI and survival among patients with LOS in the ICU LOS or connection to a ventilator. However, obese patients with COVID-19 require more care than nonobese patients because of additional comorbidities, higher inflammation, and a weaker immune system.

14.
Urmia Medical Journal ; 32(10):782-792, 2022.
Article in English | GIM | ID: covidwho-2012533

ABSTRACT

Background & Aims: Favipiravir is an antiviral drug that is widely used in patients with Covid-19. The aim of this study was to review the systematic review and meta-analysis studies of Favipiravir in patients with Covid-19. Materials & Methods: An electronic search was conducted in PubMed, Scopus, Cochrane Library, and Web of Science databases until December 2021. In addition, other databases were searched. A manual search of studies and other sources was also conducted to find evidence. The Overview Quality Assessment Questionnaire tool was used to evaluate the quality of articles.

15.
Klinicka Mikrobiologie a Infekcni Lekarstvi ; 26(3):80-85, 2020.
Article in Czech | GIM | ID: covidwho-2012297

ABSTRACT

Objectives: The first case of coronavirus infection in the Morawian Silesian Region was diagnosed on March 12.2020. The study aimed to describe the first wave and clinical manifestation of the coronavirus epidemic at the Department of Infectious Diseases in Oslrava. Material and methods: The sample comprised a total of 195 patients requiring hospitalization at (lie Department of Infectious Diseases in Ostrava between March 1 and August 31, 2020). The virus was diagnosed using polymerase chain reaction from nasopharyngeal swabs in 192 patients and from the bronchoalveolar lavage in one patient. In the other two patients, serological tests were applied using virus neutralization assays and ELISA specific antibodies.

16.
RADS Journal of Biological Research & Applied Sciences ; 13(1):83-122, 2022.
Article in English | CAB Abstracts | ID: covidwho-2002888

ABSTRACT

Background: COVID-19 is a global pandemic initiated in January 2020 that caused 79 million cases and more than 1.7 million deaths worldwide. The causative agent of COVID-19 is Severe Acute Respiratory Syndrome Coronavirus-2, a member of Betacoronvirus. COVID-19 patients are classified into asymptomatic, mild symptomatic, and severe symptomatic cases. Objectives: To review the prevalence, therapeutic interventions for the treatment, vaccination, and containment of COVID-19 in four quarters of 2020, emphasizing the advancements in biological studies, and the social, economic, and environmental impact of the pandemic. Methodology: Data of COVID-19 spread, identification, prevention, and control measures was analyzed. The impacts of pandemic on society, economy, and the environment were assessed.

17.
Revista Chilena de Anestesia ; 51(4):395-399, 2022.
Article in English | Scopus | ID: covidwho-1988887

ABSTRACT

Objective: Since the beginning of the 2019 global pandemic of Coronavirus Disease, using invasive mechanical ventilation as support therapy has been a critical treatment of acute respiratory failure. In the context of a collapsed health system, having an early extubation predictor becomes a useful way of supporting clinical management, by enabling to anticipate the availability of mechanical ventilators. Hence, we assessed the relationship between the progression of lactate dehydrogenase and early extubation in patients with COVID-19. Design: A retrospective study. Setting: A single private hospital in Chile. Patients: Adults aged 18 or older diagnosed with COVID-19 pneumonia and requiring mechanical ventilation, having been admitted to an ICU during the study period. Interventions: None. Measurements and Main Results: Fifty two individuals, 73% males, were included with a median age of 47.1 years old and a median body mass index of 29. Individuals extubated within the first 5 days of mechanical ventilation, early extubation group, amounted to 34.6%. The average decrease in serum lactate dehydrogenase levels was 27.5 UI/L per day (p < 0.01) in the early extubation group compared to 14.7 UI/L per day (p < 0.01) in the late extubation group (individuals extubated after day 5). During the first 48 hours, the average daily decrease was 56.7 UI/L in the early extubation group compared to 13.2 UI/L per day in late extubation group (p < 0.01). Conclusions: Serum lactate dehydrogenase daily level decrease during the first days of mechanical ventilation is associated with earlier patient extubation. © 2022 Sociedad de Anestesiologia de Chile. All rights reserved.

18.
Frontiers in Emergency Medicine ; 6(2):6, 2022.
Article in English | Web of Science | ID: covidwho-1988716

ABSTRACT

Objective: The present study was conducted to compare mechanically ventilated patients with and without COVID-19 in terms of hemodynamic instability using cardiovascular indicators. Methods: This prospective cohort study assigned intubated and mechanically ventilated patients to two groups, i.e. with COVID-19 and without COVID-19. The hemodynamic parameters measured and compared between the two groups on the first day of ICU admission and the following four consecutive days using an ultrasonic cardiac output monitor (USCOM) included cardiac output (CO), systemic vascular resistance (SVR), stroke volume (SV), flow time corrected (FTc), minute distance (MD) and potential kinetic energy (PKE). Results: Forty-three patients (males: 62.7%) were assigned to the COVID-19 group and 40 (males: 64.1%) to the one without COVID-19. Insignificant differences were observed between the two groups at baseline in terms of the mean homodynamic variables measured using the USCOM (P>0.05). The mean CO increased (P=0.020), the mean SVR insignificantly changed (P=0.267), the mean MD increased (P=0.005) and PKE decreased (P=0.066) in the COVID-19 group during the five days of evaluation. In the same period, the mean CO insignificantly changed (P=0.937), the mean SVR increased (P=0.028) and changes in MD (P=0.808) and PKE (P=0.539) were insignificant in the group without COVID-19. The two groups were not significantly different in terms of the other homodynamic parameters during the follow-up (P>0.05). Conclusion: The five-day changes in the USCOM-measured homodynamic parameters were lower in the group without COVID-19 compared to in that with COVID-19. In the group without COVID-19, no statistically-significant differences were observed between the mean follow-up values of the variables, excluding SVR, and their baseline values.

19.
Journal of the Faculty of Engineering & Architecture of Gazi University ; 38(1):176-187, 2023.
Article in Turkish | Academic Search Complete | ID: covidwho-1988669

ABSTRACT

In order to prevent the spread of Covid-19 and improve the treatment process, interest in hospital design and in-hospital transformation has increased worldwide. Since Covid-19 is not believed to be the last infectious health threat for communities around the world, it is of great importance to study existing hospital adaptations and work on obtaining more planning and design strategies for treatment and wellbeing areas. In this study it is aimed to make constructive recommendations on the basis of in-space planning and mechanical ventilation, which can be applied in hospital transformations for pandemic processes. Published guidelines and literature studies for hospitals to prevent the spread of infection have been examined, structured and unstructured interviews were conducted with architects and engineers specialized in hospital design. Also, a survey was conducted with 35 hospital workers and 4 people from the hospital management to analyze the changes made in the hospital during the Covid-19 process. Afterwards, the design plans of one of the two private hospitals studied in Turkey and the steps that can be applied in the transformation of patient rooms were explained in this article with the case study. Interdisciplinary work was carried in order to ensure infection control in hospital transformations, since it is required to make in-hospital space planning (separation/transformation of spaces, interior zoning) and ventilation (filtration, zoning of mechanical ventilation) in harmony. Suggestions were developed that could play a role in ensuring the consistency of mechanical and architectural planning in order to successfully complete hospital transformation practices to prevent the spread of infections in pandemic processes. As the transformation scenarios in this study were performed through an exemplary private hospital room in accordance with the criteria of the Turkish Ministry of Health, ventilation plans on the standard room project were detailed and shown in the conclusion section, where the transformation steps can also be adapted to other hospitals. (English) [ FROM AUTHOR] Covid-19 salgınının yayılmasını önlemek, tedavi sürecini iyileştirmek için hastane içi dönüşümlere olan ilgi dünya çapında artmıştır. Covid-19'un son bulaşıcı sağlık tehdidi olduğu düşünülmediğinden mevcut hastane uyarlamalarını incelemek, tedavi ve dinlenme alanları için gereksinime dayalı çeşitli planlama ve tasarım stratejileri geliştirme üzerine çalışmak büyük önem taşımaktadır. Bu çalışmada, pandemi süreçlerinde hastane içi dönüşümlerde uygulanabilecek mekân içi planlama ve takiben mekanik havalandırma özelinde yapıcı önerilerde bulunabilmek amaçlanmıştır. Enfeksiyonun yayılmasını önlemek için hastane kılavuz şartnameleri ve literatürdeki çalışmalar incelenmiş, hastane tasarımı üzerine uzmanlaşmış kişilerle çeşitli görüşmeler gerçekleştirilmiştir. Covid-19 sürecinde hastanelerde yapılan değişikliklerin analiz edilebilmesi içinse 35 hastane çalışanı ve 4 hastane yönetim personeliyle anket çalışması yapılmıştır. Veriler ışığında, Türkiye'de üzerinde çalışılmış iki özel-hastaneden birinin tasarım planları ile hasta odalarının dönüşümünde uygulanabilecek adımlar alan çalışmasıyla aktarılmıştır. Hastane içi dönüşümlerde enfeksiyon kontrolünün sağlanabilmesi adına mekân planlaması (alanların ayrıştırılması/dönüştürülmesi, mekân içi zonlama) ve havalandırmanın (filtrasyon, mekanik havalandırma için zonlama) uyum içinde olması gerektiğinden, dönüşümlerin planlanması aşamasında disiplinlerarası çalışma yapılmıştır. Pandemi süreçlerinde enfeksiyonun yayılmasının önlenebilmesi için hastane dönüşüm uygulamalarının mekanik ve mimari planlamalarında tutarlılığın sağlanabilmesi adına öneriler geliştirilmiştir. Dönüşüm senaryoları Türkiye Cumhuriyeti Sağlık Bakanlığı kriterlerine uygun örnek bir özel-hastane odası üzerinden gerçekleştirildiği için diğer hastanelere de uyarlanabileceği sonuç bölümünde tip proje üzerinde havalandırma planları detaylandırılarak gösterilmiştir. (Turkish) [ FROM AUTHOR] Copyright of Journal of the Faculty of Engineering & Architecture of Gazi University is the property of Gazi University, Faculty of Engineering & Architecture and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)

20.
Journal of Ankara University Faculty of Medicine ; 74(1 Suppl):53-58, 2021.
Article in English | GIM | ID: covidwho-1975126

ABSTRACT

Objectives: Clinical features and risk factors are highly variable for Coronavirus disease-2019 (COVID-19). Researchers investigate for the prediction of people who have high risk of developing severe illness and dying. The aim of this study is to examine the effect of obesity on the course of COVID-19. Materials and Methods: Patients with laboratory confirmed COVID-19 were retrospectively screened between March 11 and April 30. Anthropometric measures including standing height and body weight were measured at admission. Body mass index (BMI) was calculated and patients were classified into three groups as BMI< 25, BMI 25-29.99, and BMI30 according to the guidelines for the diagnosis and treatment of obesity in Turkey.

SELECTION OF CITATIONS
SEARCH DETAIL